Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer

Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer

Background: The FIRE-3 phase III clinical trial demonstrated the marked advantage of prolonging the median overall survival of patients with final RAS wild-type (WT) left-sided metastatic colorectal cancer (mCRC) by 38.3 months after treatment with irinotecan, fluorouracil, and leucovorin (FOLFIRI)...

Full description

Bibliographic Details
Main Authors:	Jiaqi Han MD, Desheng Xiao PhD, Chongqing Tan PhD, Xiaohui Zeng MD, Huabin Hu MD, Shan Zeng PhD, MD, Qin Jiang MD, Longjiang She MD, Linli Yao MD, Li Li MD, Lanhua Tang PhD, Jian Ma PhD, MD, Jin Huang PhD, MD, Liangfang Shen PhD, MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-02-01
Series:	Cancer Control
Online Access:	https://doi.org/10.1177/1073274820902271

Similar Items

Long-term Survival, Tolerability, and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer
by: Youngbae Jeon MD, et al.
Published: (2022-06-01)

Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma
by: Yasuhito Mitsuyama, MD, et al.
Published: (2023-09-01)

Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
by: Kei Kunimasa, MD, PhD, et al.
Published: (2021-11-01)

Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells
by: Yifan Duan MD, PhD, et al.
Published: (2020-04-01)

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
by: Yukinobu Watanabe MD, PhD, et al.
Published: (2021-11-01)

Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II): A Single-Arm, Open-Label, Phase 2 Clinical Trial
by: Makoto Hibino, MD, et al.
Published: (2022-12-01)

COMP: A Potential Early Biomarker of RAS After Lung Transplantation
by: Mirza Novo, MD, et al.
Published: (2021-08-01)

Aging is Associated With Constipation in Japanese Patients With Ulcerative Colitis: A Post Hoc Analysis
by: Sen Yagi MD, PhD, et al.
Published: (2023-11-01)

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
by: Yasunori Murata, MD, PhD, et al.
Published: (2023-12-01)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
by: Yoshihide Ueda, MD, PhD, et al.
Published: (2017-12-01)

Tumor Suppressor Effect of RBMS3 in Breast Cancer
by: Chunyang Wang MD, PhD, et al.
Published: (2021-04-01)

Comparing Three Different Anti–Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study
by: Yuki Katayama, MD, PhD, et al.
Published: (2024-03-01)

Modified Anterolateral Approach for Total Ankle Arthroplasty
by: Makoto Hirao MD, PhD, et al.
Published: (2021-06-01)

Impact of pleural effusion at an early period after posterior spinal fusion for adolescent idiopathic scoliosis on future pulmonary function and lung volume
by: Masahiro Ozaki, MD, PhD, et al.
Published: (2023-12-01)

Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis
by: Hideo Wada MD, PhD, et al.
Published: (2020-08-01)

Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective studyCentral MessagePerspective
by: Akira Hamada, MD, PhD, et al.
Published: (2023-06-01)

Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
by: Takafumi Yuki, MD, PhD, et al.
Published: (2017-01-01)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
by: Yusuke Yanagi, MD, PhD, et al.
Published: (2022-09-01)

Transumbilical Single-incision Laparoscopic Surgery for Harvesting Rib and Costal Cartilage
by: Lu Zhang, MD, PhD, et al.
Published: (2022-03-01)

A successful case of a para-aortic lymphocele treated with autologous peripheral blood injection
by: Keiji Nishibeppu, MD, et al.
Published: (2017-12-01)

Successful Laparoscopic Treatment of Pancreatic Metastasis From Sigmoid Colon Cancer: A Case Report
by: Masatsugu Ishii MD, PhD, et al.
Published: (2022-04-01)

Assessing Cut-off Points of Eosinophils, Nasal Polyp, and Lund-Mackay Scores to Predict Surgery in Nasal Polyposis: A Real-World Study
by: P. Virkkula MD, PhD, et al.
Published: (2020-10-01)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
by: Katsuhiro Yoshimura, MD, PhD, et al.
Published: (2021-11-01)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
by: Yohei Yamada, MD, PhD, et al.
Published: (2018-02-01)

The ability of biomarkers to assess the severity of atopic dermatitis
by: Takeshi Nakahara, MD, PhD, et al.
Published: (2024-02-01)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
by: Fumie Akasaka-Kihara, MD, et al.
Published: (2021-09-01)

Pacemaker implantation after concomitant tricuspid valve repair in patients undergoing minimally invasive mitral valve surgery: Results from the Mini-Mitral International RegistryCentral MessagePerspective
by: Gloria Faerber, MD, PhD, et al.
Published: (2024-02-01)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
by: Łukasz Pyka MD, PhD, et al.
Published: (2023-12-01)

Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis
by: Yuhei Miyasaka, MD, PhD, et al.
Published: (2024-04-01)

Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy
by: Junko Tanizaki, MD, PhD, et al.
Published: (2023-12-01)

High Pretreatment Mean Corpuscular Volume Can Predict Worse Prognosis in Patients With Esophageal Squamous Cell Carcinoma who Have Undergone Curative Esophagectomy
by: Naoya Yoshida, MD, PhD, et al.
Published: (2022-06-01)

Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy
by: Naoya Yoshida, MD, PhD, et al.
Published: (2022-06-01)

Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
by: Keita Sasa MD, et al.
Published: (2022-12-01)

Protection From Second Warm Ischemic Injury Using a Thermal Barrier Bag in Kidney Transplantation
by: Kentaro Ide, MD, PhD, et al.
Published: (2023-03-01)

Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report
by: Yoshinari Endo, MD, et al.
Published: (2022-01-01)

Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study
by: Jiro Abe, MD, et al.
Published: (2020-06-01)

Right Ventricular Dimension for Heart Failure With Preserved Ejection Fraction Involving Right Ventricular-Vascular Uncoupling
by: Akito Nakagawa, MD, PhD, et al.
Published: (2022-11-01)

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC
by: Akira Hamada, MD, et al.
Published: (2022-05-01)

Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
by: Yuichiro Okumura, MD, et al.
Published: (2017-09-01)

Clinical Predictors of Pacing Device Implantation in Implantable Cardiac Monitor Recipients for Unexplained Syncope
by: Reina Tonegawa-Kuji, MD, PhD, et al.
Published: (2023-04-01)